Primary Citation of Related Structures:   1QIV, 1QIW
PubMed Abstract: 
An arylalkylamine-type calmodulin antagonist, N-(3, 3-diphenylpropyl)-N'-[1-R-(3, 4-bis-butoxyphenyl)ethyl]-propylene-diamine (AAA) is presented and its complexes with calmodulin are characterized in solution and in the crystal. Near-UV circular dichroism spectra show that AAA binds to calmodulin with 2:1 stoichiometry in a Ca(2+)-dependent manner ...
An arylalkylamine-type calmodulin antagonist, N-(3, 3-diphenylpropyl)-N'-[1-R-(3, 4-bis-butoxyphenyl)ethyl]-propylene-diamine (AAA) is presented and its complexes with calmodulin are characterized in solution and in the crystal. Near-UV circular dichroism spectra show that AAA binds to calmodulin with 2:1 stoichiometry in a Ca(2+)-dependent manner. The crystal structure with 2:1 stoichiometry is determined to 2.64 A resolution. The binding of AAA causes domain closure of calmodulin similar to that obtained with trifluoperazine. Solution and crystal data indicate that each of the two AAA molecules anchors in the hydrophobic pockets of calmodulin, overlapping with two trifluoperazine sites, i.e. at a hydrophobic pocket and an interdomain site. The two AAA molecules also interact with each other by hydrophobic forces. A competition enzymatic assay has revealed that AAA inhibits calmodulin-activated phosphodiesterase activity at two orders of magnitude lower concentration than trifluoperazine. The apparent dissociation constant of AAA to calmodulin is 18 nM, which is commensurable with that of target peptides. On the basis of the crystal structure, we propose that the high-affinity binding is mainly due to a favorable entropy term, as the AAA molecule makes multiple contacts in its complex with calmodulin.
Related Citations: 
Simultaneous Binding of Drugs with Different Chemical Structures to Ca 2+ Calmodulin: Crystallographic and Spectroscopic Studies Vertessy, B.G., Harmat, V., Bocskei, Z.S., Naray-Szabo, G., Orosz, F., Ovadi, J. (1998) Biochemistry 37: 15300
Crystallization and Preliminary Diffraction Analysis of Ca(2+)-Calmodulin-Drug and Apocalmodulin-Drug Complexes. Vertessy, B.G., Bocskei, Z.S., Harmath, V., Naray-Szabo, G., Ovadi, J. (1997) Proteins 28: 131
Trifluoperazine-Induced Conformational Change in Ca (2+)-Calmodulin Vandonselaar, M., Hickie, R.A., Quail, J.W., Delbaere, L.T.J. (1994) Nat Struct Biol 1: 795
Drug Binding by Calmodulin: Crystal Structure of a Calmodulin-Trifluoperazine Complex Cook, W.J., Walter, L.J., Walter, M.R. (1994) Biochemistry 33: 15259
Organizational Affiliation: 
Department of Theoretical Chemistry, Loránd Eötvös University, Budapest 112, H-1518, Hungary. harmatv@ludens.elte.hu